发明名称 |
Treatment of cancer with glufosfamide in patients not receiving insulin therapy |
摘要 |
The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment. |
申请公布号 |
US8765690(B2) |
申请公布日期 |
2014.07.01 |
申请号 |
US200812594802 |
申请日期 |
2008.04.07 |
申请人 |
Threshold Pharmaceuticals, Inc. |
发明人 |
Handisides Damian;Kroll Stewart;Duan Jian-Xin;Selick Harold E. |
分类号 |
A61K31/70 |
主分类号 |
A61K31/70 |
代理机构 |
Kilpatrick Townsend & Stockton LLP |
代理人 |
Kilpatrick Townsend & Stockton LLP |
主权项 |
1. A method of treating cancer in a patient, comprising the steps of:
(i) determining whether the patient is receiving insulin therapy, and (ii) administering a therapeutically effective amount of glufosfamide to said patient only if it is determined that the patient is not receiving insulin therapy. |
地址 |
South San Francisco CA US |